Gensaic Partners with Novo Nordisk to Develop Next-Gen Precision Therapies Gensaic, Inc., a biotechnology firm specializing in AI-driven protein design and biological insights to discover ligands for tissue-selective intracellular delivery,…
QIAGEN Takes Legal Action to Protect IP in QuantiFERON and Latent TB Testing QIAGEN NV (NYSE: QGEN; Frankfurt Prime Standard: QIA) has filed a lawsuit against bioMérieux SA (EPA: BIM)…
BostonGene to Present AI-Powered Platform at 22nd Annual Japanese Society of Medical Oncology Meeting BostonGene, a leader in AI-driven molecular and immune profiling solutions, has announced its participation in the…
BeiGene Reports Q4 & Full Year 2024 Financial Results and Update BeiGene, Inc. (NASDAQ: ONC, HKEX: 06160, SSE: 688235), soon to be rebranded as BeOne Medicines Ltd., a global leader…
BridgeBio Oncology and Helix Acquisition Announce Merger to Create Biotech Company BridgeBio Oncology Therapeutics (BBOT), a clinical-stage biopharmaceutical company focused on developing novel small molecule therapeutics for RAS and PI3Kα-targeted…
Compass Pathways Reports Q4 and Full-Year 2024 Financial Results Compass Pathways plc (Nasdaq: CMPS), a leading biotechnology company focused on advancing mental health treatment, has announced its financial results for…
eClinicalWorks and healow Genie to Enhance Patient Experience for Largest Neurology Practice eClinicalWorks®, the largest ambulatory cloud EHR provider, has announced that First Choice Neurology, Florida’s largest neurology practice with…
Demetra Holding Acquires Majority Stake in GetSet Surgical, Expanding Spine Portfolio Demetra Holding, a global leader in providing anti-infective cements, spacers, and biomaterials for orthopedic applications, has announced the acquisition…
MEDITECH Genomics Integration Boosts Targeted Cancer Care at Frederick Health Frederick Health (Frederick, MD) has introduced a groundbreaking precision medicine integration aimed at enhancing decision support with personalized recommendations based…
RDD Europe 2025 Celebrates 20 Years, Co-Organized by Aptar Pharma and RDD Online Aptar Pharma, a global leader in respiratory drug delivery solutions, and RDD Online® are proud to announce…
ImmunoPrecise Antibodies Announces Restructuring of Management Team ImmunoPrecise Antibodies (IPA) (NASDAQ: IPA), an AI-driven biotherapeutics discovery and technology company, is excited to share several important leadership changes. Kamil Isaev has…
Healx Doses First Patient in Phase 2 Trial of HLX-1502 for Neurofibromatosis Type 1 Healx, a clinical-stage biotech company utilizing AI to advance treatments for rare diseases, has announced that…